Logo

Pillar Biosciences: Vincent Ricci

Jun 14, 2022

Pillar Biosciences has appointed Vincent Ricci as CFO. Ricci has two decades of experience as an investment professional focusing on the global healthcare and life sciences industry, Pillar said. He joins the company from Davidson Kempner Capital Management, where he was responsible for equity investments in the life sciences sector. Previously, Ricci was a portfolio manager for Alliance Bernstein. He began his career at Wachovia Bank where he was a VP and senior equity analyst in Wachovia's Capital Markets division. He holds a master's degree in medical science from Drexel University College of Medicine and a bachelor's degree in economics and biology from the University of Pennsylvania.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.